Thrivent Financial For Lutherans Ardelyx, Inc. Transaction History
Thrivent Financial For Lutherans
- $50.8 Billion
- Q3 2025
A detailed history of Thrivent Financial For Lutherans transactions in Ardelyx, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 156,428 shares of ARDX stock, worth $918,232. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,428
Previous 205,444
23.86%
Holding current value
$918,232
Previous $805,000
7.08%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARDX
# of Institutions
244Shares Held
160MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...